Solventum Corporation logo

Solventum Corporation (KB7)

Market Open
26 Feb, 15:32
XDUS XDUS
64. 40
+1.6
+2.55%
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
62.8
Previous Close
Day Range
62.6 64.4
Year Range
54.6 80.5
Want to track KB7 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
SOLV earnings report is expected in 64 days (6 May 2026)

Summary

KB7 trading today higher at €64.4, an increase of 2.55% from yesterday's close, completing a monthly decrease of -3.01% or €2. Over the past 12 months, KB7 stock lost -3.01%.
KB7 is not paying dividends to its shareholders.
The last earnings report, released on Feb 26, 2026, missed the consensus estimates by -0.18%. On average, the company has fell short of earnings expectations by -0.15%, based on the last three reports. The next scheduled earnings report is due on May 06, 2026.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NYSE (USD).

KB7 Chart

Solventum (SOLV) is a Top-Ranked Value Stock: Should You Buy?

Solventum (SOLV) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 hours ago
Solventum: Improvements Come Slow

Solventum: Improvements Come Slow

Solventum shares have traded sideways post-spin, as investors digest separation impacts, stranded costs, and recent capital allocation moves. Despite a $4.1B divestment and targeted $500M cost savings, 2025 results showed minimal free cash flow and only modest earnings growth. 2026 guidance calls for 2-3% organic sales growth and adjusted EPS of $6.50, but free cash flow remains weak at ~$200M.

Seekingalpha | 17 hours ago
Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down

Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down

SOLV's Q4 earnings and revenues beat estimates, driven by organic growth across MedSurg, Dental and HIS, despite margins declined.

Zacks | 3 days ago

Solventum Corporation (KB7) FAQ

What is the stock price today?

The current price is €64.40.

On which exchange is it traded?

Solventum Corporation is listed on XDUS.

What is its stock symbol?

The ticker symbol is KB7.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on May 06, 2026.

Has Solventum Corporation ever had a stock split?

No, there has never been a stock split.

Solventum Corporation Profile

Software Industry
Information Technology Sector
Bryan C. Hanson CEO
XDUS Exchange
US83444M1018 ISIN
US Country
22,000 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Solventum Corporation is a cutting-edge healthcare company established in 2023 and headquartered in Saint Paul, Minnesota. Specializing in the development, manufacture, and commercialization of diverse solutions aimed at addressing urgent customer and patient needs, the company operates across four main segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. Solventum Corporation stands out in the healthcare industry by offering a wide-ranging portfolio of innovative products and services, demonstrating its commitment to improving healthcare outcomes and enhancing the efficiency of medical and dental professions.

Products and Services

  • Medsurg: This segment targets the improvement of surgical and critical care through advanced products. Notably, it offers:
    • Advanced wound care for optimal healing.
    • Intravenous (I.V.) site management to prevent complications.
    • Sterilization assurance products for maintaining high hygiene standards.
    • Temperature management solutions to enhance patient comfort and outcomes.
    • Surgical supplies, including essentials for operating rooms.
    • High-quality stethoscopes for precise diagnostics.
    • Medical electrodes designed for accurate patient monitoring.
  • Dental Solutions: This segment delivers comprehensive dental and orthodontic products. Among these are:
    • Orthodontic brackets and aligners for a range of corrective procedures.
    • Restorative cements and bonding agents, essential for various dental works.
  • Health Information Systems: Focused on enhancing the efficiency of healthcare documentation and management through:
    • Computer-assisted, physician documentation tools to streamline processes.
    • Direct-to-bill and coding automation for accurate billing.
    • Classification methodologies to aid in patient data organization.
    • Speech recognition and data visualization platforms for better data interaction.
  • Purification and Filtration: Providing technologies that ensure purity and cleanliness, this segment manufactures:
    • Filters and purifiers for air and water, ensuring environmental safety.
    • Cartridges and membranes designed for specific filtration needs.

Contact Information

Address: 3M Center
Phone: 651-733-1110